The value of ongoing surveillance on the prevalence of contact sensitization by Schuttelaar, M. L. A.
 
 
 University of Groningen
The value of ongoing surveillance on the prevalence of contact sensitization
Schuttelaar, M. L. A.
Published in:
BRITISH JOURNAL OF DERMATOLOGY
DOI:
10.1111/bjd.19153
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Schuttelaar, M. L. A. (2020). The value of ongoing surveillance on the prevalence of contact sensitization.
BRITISH JOURNAL OF DERMATOLOGY, (5), 800-801. https://doi.org/10.1111/bjd.19153
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the




British Journal of Dermatology
The value of ongoing surveillance on the
prevalence of contact sensitization
DOI: 10.1111/bjd.19153
Linked Article: Uter et al. Br J Dermatol 2020; DOI: 10.
1111/bjd.18946
In this issue of the BJD, Uter et al. describe the results of an
ongoing surveillance study on the prevalence of contact sensi-
tization in the population of Germany, Austria and Switzer-
land.1 It is, as the authors rightly comment, not based on
patch testing samples of the general population, but ‘aimed
testing’ in patients visiting the departments that are contribut-
ing to the database. Because reading a patch test result is
prone to subjectivity and has a degree of interobserver and
interdepartmental variability, it is reassuring to note that the
participating centres meet regularly to harmonize their proce-
dures, although it is not clear whether random external moni-
toring visits are being performed.2 It is still being debated
whether patch test data from clinics, obtained by ‘aimed test-
ing’, are indicative of what is happening in the general popu-
lation. A few studies seem to confirm that, at least in a
number of European countries, it is indicative.3 It is important
to realize that the large dataset presented by Uter et al. is lim-
ited to the European baseline series. This series is supposed to
be fairly representative, but a word of caution is needed
because the hair dye ingredient para-phenylenediamine is no
longer routinely patch tested in Germany.
Large datasets allow researchers to show time trends. Indeed,
Uter et al. show time trends in positive reactions to the preserva-
tives methylisothiazolinone (MI) and methylchloroisothiazoli-
none (MCI)/MI, which is a long-term indicator for MI allergy.
The high prevalence of MI contact allergy, which had its peak
around 2013–2014 in Europe, was a major trigger to ban of the
use of MI in leave-on cosmetic products and restrict the maxi-
mum permissible level to 15 p.p.m. in rinse-off cosmetics.4,5
The current publication by Uter et al. shows the rise and fall of
contact allergy to MI, which demonstrates the success of the
preventive measures that were implemented.
The data presented by Uter et al. on sensitization to the fra-
grances support the value of ongoing surveillance, because fra-
grance-induced contact allergy is still considered to be of high
concern. Industry is more and more relying on nonanimal,
in vitro tests to assess the potency of sensitizers that are present
in marketed consumer products, to be used in a quantitative
risk assessment (QRA).6 This is promising but also shows the
importance of collecting and monitoring well-performed patch
test data as a kind of feedback loop to the more ‘predictive’
QRA. Such a well-monitored feedback loop is currently being
implemented by the Extended Fragrance Ingredients Surveil-
lance Study, to monitor the frequency of contact allergy to a
defined group of existing ingredients and also to new fra-
grance ingredients, initiated by the International Dialogue for
the Evaluation of Allergens project (IDEA; https://www.idea
project.info).
Together, large datasets such as that presented by Uter et al.
allow researchers to spot discrepancies and important time
trends, which trigger us to regulate exposure to substances,
for example by cosmetics regulation.
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